πŸ‡ΊπŸ‡Έ FDA

Intelligence Β· Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors β€” phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
20,548
Companies
1,769
Drugs tracked
4,797

Quick answer

NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text β€” searchable for business development and competitive intelligence.

9,250 results for β€œIO” Clear

  1. saproterin dihydrochloride

    BioMarin Pharmaceutical Australia Pty Ltd

    Phenylketonuria

    approved small molecule completed

    1 trial

  2. sodium iodide

    United Therapeutics Europe Ltd

    Transient Hypothyroxinemia

    approved small molecule completed

    1 trial

  3. split-virion, adjuvanted H1N1 vaccine of 7.5 ΞΌg per dose

    Sinovac Research and Development Co.,

    Influenza

    approved mab completed

    1 trial

  4. sublingual nicotine

    BRIGHT MINDS BIOSCIENCES INC.

    Nicotine Dependence

    approved small molecule completed

    1 trial

  5. telmisartan

    Boehringer Ingelheim

    Hypertension

    approved small molecule completed

    1 trial

  6. ticagrelor

    The First People's Hospital of Lianyungang

    Inflammation

    approved small molecule completed

    1 trial

  7. tiotropium 18 mcg

    Boehringer Ingelheim

    Pulmonary Disease, Chronic Obstructive

    approved small molecule completed

    1 trial

  8. transdermal nicotine replacement therapy

    BRIGHT MINDS BIOSCIENCES INC.

    Smoking

    approved small molecule active

    1 trial

  9. treatment with CAZ-AVI

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Patients With Critically Ill Infections

    approved small molecule active

    1 trial

  10. treprostinil sodium

    United Therapeutics Europe Ltd

    Pulmonary Arterial Hypertension

    approved small molecule completed

    1 trial

  11. treprostinil sodium

    United Therapeutics Europe Ltd

    Pulmonary Hypertension

    approved small molecule completed

    1 trial

  12. treprostinil sodium

    United Therapeutics Europe Ltd

    Hypertension, Pulmonary

    approved small molecule terminated

    2 trials

  13. umeclidinium 62.5 Β΅g and vilanterol 25 Β΅g

    Theravance Biopharma Ireland Umited

    COPD (Chronic Obstructive Pulmonary Disease)

    approved small molecule active

    1 trial

  14. vaccinated with Sabin IPV

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Polio

    approved mab completed

    1 trial

  15. varenicline

    BRIGHT MINDS BIOSCIENCES INC.

    Cigarette Smoking

    approved small molecule completed

    2 trials

  16. vortioxetine

    Takeda

    Depression

    approved small molecule completed

    1 trial

  17. zyban

    BRIGHT MINDS BIOSCIENCES INC.

    Smoking Cessation

    approved small molecule completed

    1 trial

  18. 0 ul of ondansetron

    Hospital Authority, Hong Kong

    Blood Coagulation Disorder

    small molecule active

    1 trial

  19. 0.01% concentration atropine drops

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Acupressure

    small molecule active

    1 trial

  20. 0.1% bromfenac ophthalmic solution

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Cataract

    small molecule completed

    1 trial

  21. 0.9% NaCl physiological saline

    Hospital Authority, Hong Kong

    Acute Respiratory Tract Infections

    small molecule active

    1 trial

  22. 1.23% fluoride foam application

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Dental Caries in Children

    small molecule completed

    1 trial

  23. 10% N2O

    BRIGHT MINDS BIOSCIENCES INC.

    Opioid-Related Disorders

    small molecule completed

    1 trial

  24. 11UCB-J PET Scan

    BRIGHT MINDS BIOSCIENCES INC.

    Opiate Dependence

    other completed

    1 trial

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync β€” verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources